近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation Wu X#, Yu Y#, Wang M#, Dai D, Yin J, Liu W, Kong D, Tang S, Meng M, Gao T, Zhang Y, Zhou Y, Guan N, Zhao S, Ye H*. Nature Communications.2024 Feb 6;15(1):1122. doi: 10.1038/s41467-024-45383-z.
A programmable protease-based protein secretion platform for therapeutic applications Xinyi Wang, Liping Kang, Deqiang Kong, Xin Wu, Yang Zhou, Guiling Yu, Di Dai & Haifeng Ye*. Nature Chemical Biology.2023 Oct 23. doi:https://doi.org/10.1038/s41589-023-01433-z.
Engineering antiviral immune-like systems for autonomous virus detection and inhibition in mice Wang Y, Xu Y, Tan CW, Qiao L, Chia WN, Zhang H, Huang Q, Deng Z, Wang Z, Wang X, Shen X, Liu C, Pei R, Liu Y, Xue S, Kong D, Anderson DE, Cai F, Zhou P, Wang LF*, Ye H* Nature Communications. 2022 Dec; 13, 7629.doi:10.1038/s41467-022-35425-9.
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy Yu Y, Wu X, Wang M, Liu W, Zhang L, Zhang Y, Hu Z, Zhou X, Jiang W, Zou Q, Cai F, Ye H* Nature Communications. 2022 Oct;13, 6357. doi:10.1038/s41467-022-33891-9.
A small and highly sensitive red/far-red optogenetic switch for applications in mammals Yang Zhou#, Deqiang Kong#, Xinyi Wang, Guiling Yu, Xin Wu, Ningzi Guan, Wilfried Weber & Haifeng Ye* Nat Biotechnol. 2022 Feb;40(2):262-272. doi: 10.1038/s41587-021-01036-w.
Genetic-code-expanded cell-based therapy for treating diabetes in mice Chao Chen#, Guiling Yu#, Yujia Huang#, Wenhui Cheng, Yuxuan Li, Yi Sun, Haifeng Ye* & Tao Liu* Nature Chemical Biology, 2022 Feb; 18, 47–55. doi: 10.1038/s41589-021-00899-z.
Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control Guiling Yu, Mingliang Zhang, Ling Gao, Yang Zhou, Longliang Qiao, Jianli Yin, Yiwen Wang, Jian Zhou*, and Haifeng Ye* Molecular Therapy.2022 Jan 5;30(1):341-354. doi: 10.1016/j.ymthe.2021.09.004.
Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol Linfeng Yang, Jianli Yin, Jiali Wu, Longliang Qiao, Evan M Zhao, Fengfeng Cai, Haifeng Ye* Proc Natl Acad Sci USA. 2021 Aug 24;118(34):e2106612118. doi: 10.1073/pnas.2106612118.
A versatile genetic control system in mammalian cells and mice responsive to clinically licensed sodium ferulate Yi Wang#, Shu Liao#, Ningzi. Guan, Yuanxiao. Liu, Kaili. Dong, Wilfried Weber, Haifeng Ye* Science Advances. 2020, 6, eabb9484.doi: 10.1126/sciadv.abb9484.
A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice Jiali Wu#, Meiyan Wang#, Xueping Yang#, Chengwei Yi, Jian Jiang, Yuanhuan Yu，Haifeng Ye* Nature Communications. 2020 Jul 24;11(1):3708. doi: 10.1038/s41467-020-17530-9.
Engineering a far-red light–activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors Yuanhuan Yu, Xin Wu, Ningzi Guan, Jiawei Shao, Huiying Li, Yuxuan Chen, Yuan Ping, Dali Li and Haifeng Ye* Science Advances. 2020, Vol. 6, no. 28, eabb1777 .doi: 10.1126/sciadv.abb1777.
Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice Krzysztof Krawczyk, Shuai Xue, Peter Buchmann, Ghislaine Charpin-El-Hamri, Pratik Saxena, Marie-Didiée Hussherr, Jiawei Shao, Haifeng Ye, Mingqi Xie, Martin Fussenegger* Science. 2020 May 29;368(6494):993-1001. doi: 10.1126/science.aau7187.
A green tea–triggered genetic control system for treating diabetes in mice and monkeys Jianli Yin, Linfeng Yang, Lisha Mou, Kaili Dong, Jian Jiang, Shuai Xue, Ying Xu, Xinyi Wang, Ying Lu, Haifeng Ye* Science Translational Medicine. 2019 Oct 23;11(515):eaav8826. doi: 10.1126/scitranslmed.aav8826. (Cover story)
Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation Jiawei Shao, Meiyan Wang, Guiling Yu, Sucheng Zhu, Yuanhuan Yu, Boon Chin Heng, Jiali Wu, Haifeng Ye* Proc Natl Acad Sci USA. 2018 Jul 17;115(29):E6722-E6730. doi: 10.1073/pnas.1802448115.
A synthetic free fatty acid-regulated transgene switch in mammalian cells and mice Ying Liu, Ghislaine Charpin-EI Hamri, Haifeng Ye, Martin Fussenegger* Nucleic Acids Res. 2018 Oct 12;46(18):9864-9874.doi: 10.1093/nar/gky805.
Immunomimetic Designer Cells Protect Mice from MRSA Infection Ying Liu, Peng Bai, Anne-Kathrin Woischnig, Ghislaine Charpin-El Hamri, Haifeng Ye, Marc Folcher, Mingqi Xie, Nina Khanna, Martin Fussenegger* Cell. 2018 Jul 12;174(2):259-270.e11. doi:10.1016/j.cell.2018.05.039.Epub 2018 Jun 21.
Smartphone-controlled opto-genetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice Jiawei Shao, Shuai Xue, Guiling Yu, Yuanhuan Yu, Xueping Yang, Yu Bai, Sucheng Zhu, Linfeng Yang, Jianli Yin, Yidan Wang, Shuyong Liao, Sanwei Guo, Mingqi Xie, Martin Fussenegger, Haifeng Ye* Science Translational Medicine. 2017 Apr 26;9(387):eaal2298. doi:10.1126/scitranslmed.aal2298.(Cover story)
A synthetic biology-inspired therapeutic strategy for targeting and treating hepatogenous diabetes. Shuai Xue, Jianli Yin, Jiawei Shao, Yuanhuan Yu, Linfeng Yang,Yidan Wang, Mingqi Xie, Martin Fussenegger and Haifeng Ye* Molecular Therapy. 2017 Feb 1;25(2):443-455. doi: 10.1016/j.ymthe.2016.11.008. (corresponding author)
Self-adjusting synthetic gene circuit for correcting insulin resistance Haifeng Ye* ?, Mingqi Xie?, Shuai Xue, Ghislaine Charpin-El Hamri, Jianli Yin, Henryk Zulewskiand Martin Fussenegger* Nature Biomedical Engineering. 2017 Jan;1(1):0005.doi: 10.1038/s41551-016-0005. (co-first and co-corresponding author)
β-cell-mimetic designer cells provide closed-loop glycemic control Mingqi Xie, Haifeng Ye, Hui Wang, Ghislaine Charpin-El Hamri, Claude Lormeau, Pratik Saxena, J?rg Stelling* and Martin Fussenegger* Science. 2016 Dec;354(6317):1296-1301. doi: 10.1126/science.aaf4006.
A synthetic biology-based device prevents liver injury in mice Peng Bai, Haifeng Ye, Mingqi Xie, Pratik Saxena, Henryk Zulewski, Ghislaine Charpin-El Hamri, Valentin Djonovand，Martin Fussenegger* Journal of Hepatology. 2016 Jul;65(1):84-94. doi: 10.1016/j.jhep.2016.03.020.
Cosmetics-triggered percutaneous remote control of transgene expression in mice Wang H, Haifeng Ye, Xie M, Daoud El-Baba M, Fussenegger M* Nucleic Acids Res. 2015 Aug 18;43(14):e91. doi: 10.1093/nar/gkv326.
Antagonistic control of a dual-input mammalian gene switch by food additives Mingqi Xie, Haifeng Ye, Hamri GC, Martin Fussenegger* Nucleic Acids Res. 2014 Aug;42(14):e116. doi: 10.1093/nar/gku545.
Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome Haifeng Ye, Charpin-El Hamri, G., Zwicky, K., Christen, M., Marc Folcher, Martin Fussenegger* Proc Natl Acad Sci USA. 2013 Jan 2;110(1):141-6.doi: 10.1073/pnas.1216801110.
A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice Haifeng Ye,Daoud-El Baba, M., Peng, R.W. & Martin Fussenegger* Science. 2011 Jun 24;332(6037):1565-8. doi: 10.1126/science.1203535.
Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice Haifeng Ye, Jin L, Hu R, Yi Z, Li J, Wu Y, Xi X, Wu Z* Biomaterials. 2006 Dec;27(35):5958-65.
京公网安备 11010802027423号